Did you know that majority of PTSD incidents occur outside of the military? The idea here is that when identifying stakeholders within your disease state, you should cast a wide net because some of the "unusual suspects" might end up being the right partners.  In today's episode, Snowfish President David Fishman highlights the importance of stakeholder groups in the life sciences. 

Consulting and Special Projects, what are they? In this episode, we sit down with Snowfish President David Fishman. Through the course of our conversation, he explains what types of projects fall under the umbrella term of Consulting and Special projects. David also highlights three examples of Snowfish's work. 

Biomarkers and Translational tools, what are they? More importantly, how can they benefit your existing pipeline? Alex sits down with Snowfish Managing Director Melissa Hammond to discuss this promising field. 

I would like to welcome everyone to the first episode of the Snowfish Podcast. For those who do not know us, Snowfish provides consulting services to life science and medical device companies. Our specialties include market landscape and KOL Mapping, which brings us to the topic of today’s episode: the APP landscape. APPs are Nurse Practitioners and Physicians Assistants who can prescribe and see their own patients, but are not medical doctors. Nevertheless, they are crucial for pharmaceutical companies to connect with. To learn more, we sat down with Tom Ullian and Kristan Holstead of RNsights. RNsights delivers APP expertise to clients and has a firm understanding of the APP market. They recently released a detailed report about APPs.